UPDATE
: Thursday, December 12, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
HOME
Hospital
SNUH succeeds in allogeneic hair transplant without immunosuppressant
Lee Han-soo
승인 2019.01.10 16:06
댓글 0
Comments
0
Please leave the first comment.
GC Labcell releases trial results of NK-cell combination treatment
Laparoscopic surgery effective in treating cancer in pancreas head
Eli Lilly Korea launches migraine prevention drug
Yuhan to start phase-3 trial on lung cancer drug Lazertinib
GC Labcell releases trial results of NK-cell combination treatment
Laparoscopic surgery effective in treating cancer in pancreas head
Eli Lilly Korea launches migraine prevention drug
Yuhan to start phase-3 trial on lung cancer drug Lazertinib
여백
Most viewed
1
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
2
Syntekabio, CHA Hospital to co-develop immunotherapy
3
‘Endogenous T cells have high potential of treating blood, solid tumors’
4
AbbVie’s Venclexta nears insurance benefit
5
Aprogen, 1st Korean biotech firm to win unicorn status
6
AMC unravels clues in treating relapsing, metastatic bladder cancer
7
Korea selected as 'Medical Tourism Destination of the Year'
8
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
9
AbbVie's releases new data for chronic lymphocytic leukemia treatment
10
ABL Bio unveils new bispecific antibody at US meet
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top